• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有不确定恶性表现的管状大汗腺腺瘤:1例报告及文献复习

Tubular Apocrine Adenoma with Uncertain Malignant Findings: Report of a Case and Review of the Literature.

作者信息

Tokuchi Keiko, Yanagi Teruki, Maeda Takuya, Nakazato Shinichi, Miyamoto Kodai, Tomaru Utano, Anan Takashi, Ujiie Hideyuki

机构信息

Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan.

出版信息

Case Rep Dermatol. 2025 Apr 10;17(1):240-245. doi: 10.1159/000545712. eCollection 2025 Jan-Dec.

DOI:10.1159/000545712
PMID:40567508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12193818/
Abstract

INTRODUCTION

Tubular apocrine adenoma (TAA) is a rare sweat gland tumor, usually presenting as a well-defined, red to brown nodule on the scalp. Generally, TAA is considered as benign tumor; however, it may be difficult to differentiate TAA from metastatic or primary carcinoma.

CASE PRESENTATION

A woman in her 90s presented with a pale red nodule on her right posterior auricle for 3 years. Histology showed several tubular structures contained two layers in the dermis. These showed decapitation secretion. At the periphery of the lesion, squamoid tumor cells formed nest-like patterns. Some squamoid tumor cells exhibited multinucleation. Based on the histopathological, immunohistochemical, and molecular biology findings, the tumor was diagnosed as TAA with undefined malignant changes.

CONCLUSION

TAA is a rare sweat gland neoplasm. Although TAA is generally benign, it can exhibit aggressive features, making thorough pathological evaluation crucial to rule out malignancy.

摘要

引言

管状大汗腺腺瘤(TAA)是一种罕见的汗腺肿瘤,通常表现为头皮上边界清晰、呈红色至棕色的结节。一般来说,TAA被认为是良性肿瘤;然而,将TAA与转移性或原发性癌区分开来可能具有挑战性。

病例报告

一名90多岁的女性,其右耳后出现淡红色结节3年。组织学检查显示真皮内有几个包含两层结构的管状结构,呈现断头分泌现象。在病变周边,鳞状肿瘤细胞形成巢状结构,部分鳞状肿瘤细胞表现为多核。基于组织病理学、免疫组织化学和分子生物学检查结果,该肿瘤被诊断为具有未明确恶性改变的TAA。

结论

TAA是一种罕见的汗腺肿瘤。虽然TAA通常为良性,但它可能具有侵袭性特征,因此进行全面的病理评估对于排除恶性肿瘤至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289b/12193818/5d7018d4f234/cde-2025-0017-0001-545712_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289b/12193818/5d7018d4f234/cde-2025-0017-0001-545712_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289b/12193818/5d7018d4f234/cde-2025-0017-0001-545712_F01.jpg

相似文献

1
Tubular Apocrine Adenoma with Uncertain Malignant Findings: Report of a Case and Review of the Literature.具有不确定恶性表现的管状大汗腺腺瘤:1例报告及文献复习
Case Rep Dermatol. 2025 Apr 10;17(1):240-245. doi: 10.1159/000545712. eCollection 2025 Jan-Dec.
2
Beckwith-Wiedemann Syndrome贝克威思-维德曼综合征
3
Cutaneous apocrine-derived eyelid lesions: a series.
Orbit. 2025 Jun 18:1-10. doi: 10.1080/01676830.2025.2514249.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.术中冰冻切片分析用于诊断可疑盆腔肿块中的早期卵巢癌。
Cochrane Database Syst Rev. 2016 Mar 1;3(3):CD010360. doi: 10.1002/14651858.CD010360.pub2.
6
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类:一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.

本文引用的文献

1
Primary cutaneous apocrine carcinoma, arising in tubular apocrine adenoma.原发性皮肤大汗腺癌,源自管状大汗腺瘤。
J Cutan Pathol. 2023 Dec;50(12):1042-1047. doi: 10.1111/cup.14509. Epub 2023 Sep 17.
2
Tubular apocrine adenoma: A rare and controversial tumor.
J Dermatol. 2019 Jan;46(1):e45-e46. doi: 10.1111/1346-8138.14494. Epub 2018 Jun 4.
3
p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases.p40 在区分原发性皮肤附属器癌与皮肤转移癌方面比 p63 具有更好的特异性。
Hum Pathol. 2014 May;45(5):1078-83. doi: 10.1016/j.humpath.2014.01.006. Epub 2014 Jan 28.
4
Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.合子后 HRAS 和 KRAS 突变导致皮脂痣和 Schimmelpenning 综合征。
Nat Genet. 2012 Jun 10;44(7):783-7. doi: 10.1038/ng.2316.
5
Is tubular apocrine adenoma a distinct clinical entity?
Am J Dermatopathol. 1993 Oct;15(5):482-7. doi: 10.1097/00000372-199310000-00014.
6
Tubular apocrine adenoma with perineural invasion.
J Am Acad Dermatol. 1984 Oct;11(4 Pt 1):639-42. doi: 10.1016/s0190-9622(84)70221-0.
7
Sweat gland differentiation in mammary adenoid cystic carcinoma.
Cancer. 1979 May;43(5):1752-60. doi: 10.1002/1097-0142(197905)43:5<1752::aid-cncr2820430526>3.0.co;2-8.